The company
CAMP4 Therapeutics Corporation
CAMP · Nasdaq
CAMP stood above a rising 150-day average in 23 of the last 52 weekly readings, and has been out of that trend for the last 25 weeks. It is 24.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 25
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $198K
- Insider sales, 12 months
- $5.0M
- Officials’ trades on record
- 2
- Institutions holding
- 61 (+16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
2 disclosed lines: House 2, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 2 Oct 2015filed 20 Oct 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $15k–$50k | 28 Jan 2015filed 10 Feb 2015 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Kelly GoldChief Financial Officer | bought | 10,000at $3.96 | 31 Aug 2026filed 2 Sep 2026 |
| Andrew J. SchwabDirector | sold | 400,000at $4.04 | 27 Aug 2026filed 31 Aug 2026 |
| Andrew J. SchwabDirector | sold | 10at $4.50 | 24 Aug 2026filed 26 Aug 2026 |
| Andrew J. SchwabDirector | sold | 32,018at $4.50 | 21 Aug 2026filed 21 Aug 2026 |
| Andrew J. SchwabDirector | sold | 114,700at $4.54 | 20 Aug 2026filed 21 Aug 2026 |
| Andrew J. SchwabDirector | sold | 45,147at $4.76 | 19 Aug 2026filed 21 Aug 2026 |
| Daniel TardiffChief Scientific Officer | sold | 1,738at $4.76 | 19 Aug 2026filed 19 Aug 2026 |
| 5am Partners Vi, Llc10% owner | bought | 3,179,558at $1.53 | 3 Aug 2026filed 5 Aug 2026 |
| Josh Mandel-BrehmChief Executive Officer | bought | 6,551at $1.65 | 3 Aug 2026filed 5 Aug 2026 |
| Kelly GoldChief Financial Officer | bought | 6,551at $1.65 | 3 Aug 2026filed 5 Aug 2026 |
| Yuri MaricichChief Medical Officer | bought | 6,551at $1.65 | 3 Aug 2026filed 5 Aug 2026 |
| Richard A. YoungDirector | bought | 16,378at $1.65 | 3 Aug 2026filed 5 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 6,307,636$27.6M | +6,307,636 |
| 5AM Venture Management, LLCunchanged · filed 14 Aug 2026 | 5,869,091$25.6M | 00.0% |
| FMR LLCreduced · filed 13 Aug 2026 | 4,904,339$21.4M | -29,093−0.6% |
| Vivo Capital, LLCunchanged · filed 14 Aug 2026 | 4,246,568$18.6M | 00.0% |
| Balyasny Asset Management L.P.reduced · filed 14 Aug 2026 | 2,575,724$11.3M | -56,713−2.2% |
| a16z Capital Management, L.L.C.unchanged · filed 14 Aug 2026 | 2,125,339$9.3M | 00.0% |
| ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 2026 | 1,960,784$8.6M | 00.0% |
| Trails Edge Capital Partners, LPreduced · filed 14 Aug 2026 | 1,932,937$8.4M | -6,626−0.3% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 1,644,134$7.2M | +1,187,763+260.3% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,533,489$6.7M | -1,279−0.1% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.